Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 111

Similar articles for PubMed (Select 16096369)

1.

High frequency somatic mutations in RASSF1A in nasopharyngeal carcinoma.

Pan ZG, Kashuba VI, Liu XQ, Shao JY, Zhang RH, Jiang JH, Guo C, Zabarovsky E, Ernberg I, Zeng YX.

Cancer Biol Ther. 2005 Oct;4(10):1116-22. Epub 2005 Oct 13.

2.

High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma.

Lo KW, Kwong J, Hui AB, Chan SY, To KF, Chan AS, Chow LS, Teo PM, Johnson PJ, Huang DP.

Cancer Res. 2001 May 15;61(10):3877-81.

3.

Inactivation of RASSF1A, RARbeta2 and DAP-kinase by promoter methylation correlates with lymph node metastasis in nasopharyngeal carcinoma.

Fendri A, Masmoudi A, Khabir A, Sellami-Boudawara T, Daoud J, Frikha M, Ghorbel A, Gargouri A, Mokdad-Gargouri R.

Cancer Biol Ther. 2009 Mar;8(5):444-51. Epub 2009 Mar 21.

4.

Inactivation of LARS2, located at the commonly deleted region 3p21.3, by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma.

Zhou W, Feng X, Li H, Wang L, Zhu B, Liu W, Zhao M, Yao K, Ren C.

Acta Biochim Biophys Sin (Shanghai). 2009 Jan;41(1):54-62.

5.

RASSF1A is a target tumor suppressor from 3p21.3 in nasopharyngeal carcinoma.

Chow LS, Lo KW, Kwong J, To KF, Tsang KS, Lam CW, Dammann R, Huang DP.

Int J Cancer. 2004 May 10;109(6):839-47.

PMID:
15027117
6.

Expression of RASSF1A gene in nasopharyngeal carcinoma.

Peng H, Zhao T, Yao KT.

Di Yi Jun Yi Da Xue Xue Bao. 2003 Jul;23(7):673-6.

PMID:
12865217
7.

Evaluation of hypermethylated tumor suppressor genes as tumor markers in mouth and throat rinsing fluid, nasopharyngeal swab and peripheral blood of nasopharygeal carcinoma patient.

Chang HW, Chan A, Kwong DL, Wei WI, Sham JS, Yuen AP.

Int J Cancer. 2003 Jul 20;105(6):851-5. Erratum in: Int J Cancer. 2003 Oct 10;106(6):984.

PMID:
12767073
8.

p16 gene alterations in nasopharyngeal carcinoma.

Lo KW, Huang DP, Lau KM.

Cancer Res. 1995 May 15;55(10):2039-43.

9.

Alterations of BLU, a candidate tumor suppressor gene on chromosome 3p21.3, in human nasopharyngeal carcinoma.

Liu XQ, Chen HK, Zhang XS, Pan ZG, Li A, Feng QS, Long QX, Wang XZ, Zeng YX.

Int J Cancer. 2003 Aug 10;106(1):60-5.

PMID:
12794757
10.

[Mutation and expression of SEMA3B and SEMA3F gene in nasopharyngeal carcinoma].

Liu XQ, Sun M, Chen HK, Li JX, Pan ZG, Long QX, Wang XZ, Zeng YX.

Ai Zheng. 2003 Jan;22(1):16-20. Chinese.

PMID:
12561429
11.

Aberrant methylation of RASSF4/AD037 in nasopharyngeal carcinoma.

Chow LS, Lo KW, Kwong J, Wong AY, Huang DP.

Oncol Rep. 2004 Oct;12(4):781-7.

PMID:
15375500
12.

[Methylation of the putative tumor suppressor gene, RASSF1A, in primary cervical tumors].

Maliukova AV, Loginov VI, Khodyrev DS, Kadyrova EL, Pronina IV, Ivanova TA, Kiselev FL, Zabarovskiń≠ NP, Braga EA.

Mol Biol (Mosk). 2004 Nov-Dec;38(6):1005-13. Russian.

PMID:
15612586
13.

Mitochondrial DNA somatic mutations are frequent in nasopharyngeal carcinoma.

Pang LJ, Shao JY, Liang XM, Xia YF, Zeng YX.

Cancer Biol Ther. 2008 Feb;7(2):198-207. Epub 2007 Nov 3.

14.

Aberrant promoter hypermethylation and silencing of the critical 3p21 tumour suppressor gene, RASSF1A, in Chinese oesophageal squamous cell carcinoma.

Wong ML, Tao Q, Fu L, Wong KY, Qiu GH, Law FB, Tin PC, Cheung WL, Lee PY, Tang JC, Tsao GS, Lam KY, Law S, Wong J, Srivastava G.

Int J Oncol. 2006 Mar;28(3):767-73.

PMID:
16465383
15.

Genetic and epigenetic alterations of DLC-1, a candidate tumor suppressor gene, in nasopharyngeal carcinoma.

Peng D, Ren CP, Yi HM, Zhou L, Yang XY, Li H, Yao KT.

Acta Biochim Biophys Sin (Shanghai). 2006 May;38(5):349-55.

16.

Presence of p53 mutations in primary nasopharyngeal carcinoma (NPC) in non-Asians of Los Angeles, California, a low-risk population for NPC.

Van Tornout JM, Spruck CH 3rd, Shibata A, Schmutte C, Gonzalez-Zulueta M, Nichols PW, Chandrasoma PT, Yu MC, Jones PA.

Cancer Epidemiol Biomarkers Prev. 1997 Jul;6(7):493-7.

17.

Identification of RASSF1A modulated genes in nasopharyngeal carcinoma.

Chow LS, Lam CW, Chan SY, Tsao SW, To KF, Tong SF, Hung WK, Dammann R, Huang DP, Lo KW.

Oncogene. 2006 Jan 12;25(2):310-6.

PMID:
16116475
18.

Reduced expression of RASSF1A in esophageal and nasopharyngeal carcinomas significantly correlates with tumor stage.

Lo PH, Xie D, Chan KC, Xu FP, Kuzmin I, Lerman MI, Law S, Chua D, Sham J, Lung ML.

Cancer Lett. 2007 Nov 18;257(2):199-205. Epub 2007 Aug 27.

PMID:
17720308
19.

Frequent hypermethylation of RASSF1A in early flat-type colorectal tumors.

Sakamoto N, Terai T, Ajioka Y, Abe S, Kobayasi O, Hirai S, Hino O, Watanabe H, Sato N, Shimoda T, Fujii H.

Oncogene. 2004 Nov 25;23(55):8900-7.

PMID:
15480433
20.

Frequent epigenetic inactivation of chromosome 3p candidate tumor suppressor genes in gallbladder carcinoma.

Riquelme E, Tang M, Baez S, Diaz A, Pruyas M, Wistuba II, Corvalan A.

Cancer Lett. 2007 May 18;250(1):100-6. Epub 2006 Nov 7.

PMID:
17084965
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk